The FDA has flagged a nationwide recall involving nearly 375,000 bottles of duloxetine delayed-release capsules after testing identified elevated levels of a potentially cancer-causing impurity. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results